Condition: Liver Cancer · Sponsor: Anhui Provincial Hospital
This study was led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close cooperation with many participating units across the country, to establish a standardized clinical information database of hepatocellular carcinoma cohorts, which will provide a guarantee for conducting high-quality real-world clinical studies and clinical research.
This description comes directly from the study's public registry record.
Ji-Zhou Wang, MD PhD · +86 13836135864 · wangjoe@ustc.edu.cn
Lianxin Liu, MD PhD · +86 13845159888 · liulx@ustc.edu.cn
Always discuss trial participation with your own doctor first.
| Anqing First People's Hospital | Anqing, Anhui, China | Recruiting |
| Anqing Municipal Hospital | Anqing, Anhui, China | Recruiting |
| Bengbu First People's Hospital | Bengbu, Anhui, China | Recruiting |
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, Anhui, China | Recruiting |
| The Second Affiliated Hospital of Bengbu Medical College | Bengbu, Anhui, China | Recruiting |
| The People's Hospital of Bozhou | Bozhou, Anhui, China | Recruiting |
| The People's Hospital of Chizhou | Chizhou, Anhui, China | Recruiting |
| The First People's Hospital of Chuzhou | Chuzhou, Anhui, China | Recruiting |
| No.2 People's Hospital of Fuyang City | Fuyang, Anhui, China | Recruiting |
| Fuyang Cancer Hospital | Fuyang, Anhui, China | Recruiting |
| Fuyang Fifth People's Hospital | Fuyang, Anhui, China | Recruiting |
| Fuyang People's Hospital | Fuyang, Anhui, China | Recruiting |
+ 26 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.